Our results are unique in a way that they demonstrate for the first time loss of PDEF is associated with aggressive phenotype in prostate cancer, and suggest that PDEF might serve as a potential marker for distinguishing aggressive prostate cancer from an indolent disease. This evidence concerns the gene SPDEF and Familial prostate cancer.